BB
DFTX

Busey Bank’s Definium Therapeutics DFTX Stock Holding History

Busey Bank’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-156,320
Closed -$572K – 356
2023
Q4 		$572K Sell
156,320
-50,000
-24% -$151K 0.02% 217
2023
Q3 		$646K Sell
206,320
-38,027
-16% -$156K 0.03% 193
2023
Q2 		$872K Hold
244,347
– – 0.04% 187
2023
Q1 		$775K Hold
244,347
– – 0.03% 197
2022
Q4 		$538K Hold
244,347
– – 0.02% 225
2022
Q3 		$855K Buy
244,347
+161,134
+194% +$1.55M 0.04% 190
2022
Q2 		$799K Hold
83,213
– – 0.04% 199
2022
Q1 		$1.39M Hold
83,213
– – 0.06% 174
2021
Q4 		$1.72M Buy
83,213
+28,751
+53% +$918K 0.07% 162
2021
Q3 		$1.9M Buy
+54,462
New +$2.35M 0.08% 148

Other funds holding DFTX

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Busey Bank's DFTX Position: Q1 2024 in Review

Busey Bank sold out of Definium Therapeutics (DFTX) in Q1 2024, closing a stake of 156,320 shares — an estimated $572K sold.

Busey Bank first reported a position in DFTX in Q3 2021 and held it in 10 quarters. The position peaked at $1.9M in Q3 2021. 135 funds tracked by Wall St. Rank hold DFTX as of Q1 2024.

  • Busey Bank reported no remaining Definium Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Busey Bank sold 156,320 Definium Therapeutics shares in Q1 2024, an estimated $572K.
  • Busey Bank first reported a position in Definium Therapeutics in Q3 2021 and held it in 10 quarters.
  • Busey Bank's Definium Therapeutics position peaked at $1.9M in Q3 2021.
  • 135 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2024.

Based on Busey Bank's 13F filing for Q1 2024, filed 23 Apr 2024.